Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Game on for life: app fights suicide in mental health patients

NCT ID NCT06358339

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a gamified mobile health app designed to reduce suicide risk in adults with mental disorders after they leave the hospital. Researchers will enroll 640 participants in Shenzhen, China, and use game-like features to encourage treatment adherence and follow-up visits. The goal is to find the best combination of gamification elements to lower suicidal thoughts and improve outpatient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 640 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For patients * Being 18 years and above; * Being diagnosed with mental disorders; * Having received inpatient care for three days or more; * Living in Shenzhen and having no plan to leave Shenzhen in the following 12 months after discharge; * Being able to use apps or WeChat (WeChat mini program) on smart phones. For lay health care supporters (LHSs) * Being 18 years and above; * Being without any diagnosis of mental disorder; * Being the lay health care supporter in the family; * Living in Shenzhen and having no plan to leave Shenzhen in the following 12 months after discharge; * Being able to use apps or WeChat (WeChat mini program) on smart phones. For the clinic and community mental health service providers * Being 18 years and above; * Having practiced in mental health service at least for 12 months. Exclusion criteria For patients * Refusing to provide written consent or be unable to provide written consent due to any cognitive problems. * Being discharged by the patient's or LHSs' demand against medical advice. * With no ID, no stable residence nor any source of income. For For lay health care supporters (LHSs) * Refusing to provide written consent. For the clinic and community mental health service providers * Refusing to provide written consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mental disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Shenzhen Kangning Hospital

    RECRUITING

    Shenzhen, Guangdong, 518020, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.